Skip to main content

Locations

About

Practice Philosophy

  • "Treat each child as if they are your own."

Honors and Awards

  • 1989 Financial Scholarship - Premedical Training Award Awarded by Physics Teacher's Association of India
  • 1999-00 Chief Resident: Sri Ramachandra Medical College and Harvard Research Institute (SRMC and RI) (Chennai - India)
  • 2008-11 California Institute of Regenerative Medicine Clinical Scholar (UC Berkeley)
  • 2008-10 Fellow of Cooley's Anemia Foundation
  • 2009-10 Young Investigator Award - American Society of Bone Marrow Transplantation (Travel)
  • 2011 Clinical Research Award - Children's Hospital Oakland Research Institute
  • 2012 Best paper in Translational Medicine from Society of Experimental Biology and Medicine for the year 2011
  • 2017 Outstanding Sub-Specialty Faculty (Teaching Award) - Pediatric Residents - University of Missouri
  • 2017 Outstanding Sub-Specialty Faculty (Teaching Award) - Medicine + Pediatrics (Med- Peds) Residents - University of Missouri
  • 2017 Best Abstract in Clinical Category 1 - University of Missouri School of Medicine; Medical Student: Kelsey Busken; Mentor: Dr. Bindu Kanathezhath Sathi
  • 2018 Best Abstract in Clinical Category II - University of Missouri School of Medicine; Resident (PGY3): Dr. Lila Wahidi; Mentor: Dr. Bindu K Sathi
  • 2018-20 American Society of Hematology Award for Next Generation of Research Scientists (HONORS) - Mentored Award - Kelsey Busken MS4; Mentor: Dr. Bindu K Sathi

Dr. Sathi is the Director of the Sickle Cell Disease Program and Apheresis Program at Valley Children's Hospital.

Prior to Valley Children’s, Dr. Sathi was the director of the Sickle Cell Disease Program at the University of Missouri School of Medicine in Columbia. She was an assistant professor of Pediatrics and served as the Director of Sickle Cell Disease Pediatric to Adult Transition clinic, Chair of Pediatric Tumor Board and principal investigator of the Central Missouri Sickle Cell Disease Program. In addition, she was the sub-principal investigator for Children’s Oncology Group (COG) for the Ellis Fischel Cancer Center.

Dr. Sathi is a member of the of Children’s Oncology Group (COG). She serves as an ad-hoc reviewer for the Journal of Infection. Her expert research has been published in peer review journals including Pediatric Blood and Cancer, Journal of Experimental Medicine and BiologyJournal of Pediatric Hematology/Oncology, Indian Journal of Medical and Pediatric Oncology and Hematology Oncology Clinics of North America. She has presented abstracts at American Society of Clinical Oncology, American Society of Hematology, American Society of Pediatric Hematology Oncology and American Society of Bone Marrow Transplantation annual meetings. She was a clinical scholar of Cooley’s Anemia Foundation and of California Institute of Regenerative Medicine.

Dr. Sathi’s areas of interest includes Sickle Cell and Hemoglobin Disorders, Iron Overload, Infection and Nutritional Optimization in immunocompromised hosts and global outreach. She is a visiting consultant at Malabar Institute of Medical Science, Kerala, India.

Dr. Sathi received her medical degree from Government Medical College Calicut in India. She then went on to complete an internship in pediatrics and a pediatric residency, both from University of Southern California, Los Angeles County Medical Center. Dr. Sathi also completed a residency in pediatrics at Sri Ramachandra Medical College and Research Institute (SRMC & RI) in Chennai, India. She completed her fellowship in pediatric hematology and oncology at UCSF Benioff Children’s Hospital Oakland.


Medical Education

  • Medical SchoolGovernment Medical College, Calicut, Kerala, India
  • FellowshipPediatric Hematology and Oncology – USCF Benioff Children’s Hospital Oakland, Oakland, CA
  • ResidencyPediatrics - Sri Ramachandra Medical College and Research Institute, Chennai, India
  • ResidencyPediatrics - University of Southern California, Los Angeles
  • InternshipPediatrics - University of Southern California, Los Angeles

Research

1. Alloimmunization, Stroke and Iron Overload in Sickle Cell Anemia
2. Late effects of chemotherapy
3. Global outreach program in Sickle Cell Anemia- Identifying factors related to milder clinical phenotype in Homozygous Sickle Cell disease in South-Indian tribal population
4. Cardiac Iron overload in transfusional siderosis
5. Guidelines for Pediatric Oncology in limited resource nations
6. Stroke in Hemoglobin SC Disease
7. SARS-CoV- 2 infection in Sickle Cell Disease


Additional Information

  • Associate Clinical Professor, UCSF Fresno Program
  • Pacific Sickle Cell Research Collaborative: Site Investigator
  • Visit Consultant: MVR Cancer Research Institute, Kerala, India
  • American Society of Hematology: Grass-roots member
  • Young Medical Oncologist of India: Member
  • Cayenne Wellness Center: Education Committee Member